{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T18:59:47Z","timestamp":1787165987028,"version":"build-2736575974"},"reference-count":87,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,8,9]],"date-time":"2022-08-09T00:00:00Z","timestamp":1660003200000},"content-version":"vor","delay-in-days":100,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["P30 GM124169"],"award-info":[{"award-number":["P30 GM124169"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["P50 AI150476"],"award-info":[{"award-number":["P50 AI150476"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01 GM104659"],"award-info":[{"award-number":["R01 GM104659"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01 GM124149"],"award-info":[{"award-number":["R01 GM124149"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005496","name":"American Foundation for Pharmaceutical Education","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005496","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008069","name":"University of California, San Francisco","doi-asserted-by":"publisher","award":["MR-15-328599"],"award-info":[{"award-number":["MR-15-328599"]}],"id":[{"id":"10.13039\/100008069","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cell Chemical Biology"],"published-print":{"date-parts":[[2022,5]]},"DOI":"10.1016\/j.chembiol.2022.03.007","type":"journal-article","created":{"date-parts":[[2022,3,31]],"date-time":"2022-03-31T12:43:49Z","timestamp":1648730629000},"page":"785-798.e19","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["Inhibiting a dynamic viral protease by targeting a non-catalytic cysteine"],"prefix":"10.1016","volume":"29","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8323-562X","authenticated-orcid":false,"given":"Kaitlin R.","family":"Hulce","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Priyadarshini","family":"Jaishankar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory M.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0369-1922","authenticated-orcid":false,"given":"Markus-Frederik","family":"Bohn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily J.","family":"Connelly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristin","family":"Wucherer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chayanid","family":"Ongpipattanakul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Regan F.","family":"Volk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shih-Wei","family":"Chuo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle R.","family":"Arkin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam R.","family":"Renslo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7704-9185","authenticated-orcid":false,"given":"Charles S.","family":"Craik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.chembiol.2022.03.007_bib1","doi-asserted-by":"crossref","first-page":"11650","DOI":"10.1021\/jacs.7b04030","article-title":"Allosteric inhibitors, crystallography, and comparative analysis reveal network of coordinated movement across human herpesvirus proteases","volume":"139","author":"Acker","year":"2017","journal-title":"J.\u00a0Am. Chem. Soc."},{"key":"10.1016\/j.chembiol.2022.03.007_bib2","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1107\/S0907444912001308","article-title":"Towards automated crystallographic structure refinement with phenix.refine","volume":"68","author":"Afonine","year":"2012","journal-title":"Acta Crystallogr. Section D Biol. Crystallogr."},{"key":"10.1016\/j.chembiol.2022.03.007_bib3","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1038\/nsb0901-810","article-title":"Molecular mechanism for dimerization to regulate the catalytic activity of human cytomegalovirus protease","volume":"8","author":"Batra","year":"2001","journal-title":"Nat. Struct. Biol."},{"key":"10.1016\/j.chembiol.2022.03.007_bib4","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1016\/j.drudis.2015.05.005","article-title":"Covalent inhibitors in drug discovery: from accidental discoveries to avoided liabilities and designed therapies","volume":"20","author":"Bauer","year":"2015","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.chembiol.2022.03.007_bib5","doi-asserted-by":"crossref","first-page":"5847","DOI":"10.1021\/bi9529972","article-title":"Flavins inhibit human cytomegalovirus UL80 protease via disulfide bond formation","volume":"35","author":"Baum","year":"1996","journal-title":"Biochemistry"},{"key":"10.1016\/j.chembiol.2022.03.007_bib6","doi-asserted-by":"crossref","first-page":"5838","DOI":"10.1021\/bi952996+","article-title":"Inhibition of human cytomegalovirus UL80 protease by specific intramolecular disulfide bond formation","volume":"35","author":"Baum","year":"1996","journal-title":"Biochemistry"},{"key":"10.1016\/j.chembiol.2022.03.007_bib7","doi-asserted-by":"crossref","first-page":"10269","DOI":"10.1021\/j100142a004","article-title":"A well-behaved electrostatic potential based method using charge restraints for deriving atomic charges: the RESP model","volume":"97","author":"Bayly","year":"1993","journal-title":"J.\u00a0Phys. Chem."},{"key":"10.1016\/j.chembiol.2022.03.007_bib8","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1107\/S139900471500303X","article-title":"REdiii: a pipeline for automated structure solution","volume":"71","author":"Bohn","year":"2015","journal-title":"Acta Crystallogr. Section D Biol. Crystallogr."},{"key":"10.1016\/j.chembiol.2022.03.007_bib9","doi-asserted-by":"crossref","first-page":"8923","DOI":"10.1021\/ja0749993","article-title":"Ruthenium-catalyzed Azide\u2212Alkyne cycloaddition: scope and mechanism","volume":"130","author":"Boren","year":"2008","journal-title":"J.\u00a0Am. Chem. Soc."},{"key":"10.1016\/j.chembiol.2022.03.007_bib10","doi-asserted-by":"crossref","first-page":"4428","DOI":"10.1021\/jm030810w","article-title":"Design and synthesis of pyrrolidine-5,5\u2018- trans- lactams (5-oxo-hexahydropyrrolo[3,2- b ]pyrroles) as novel mechanism-based inhibitors of human cytomegalovirus protease. 4. Antiviral activity and plasma stability","volume":"46","author":"Borthwick","year":"2003","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.chembiol.2022.03.007_bib11","first-page":"14E.3","article-title":"Human cytomegalovirus: propagation, quantification, and storage","volume":"14","author":"Britt","year":"2010","journal-title":"Curr. Protoc. Microbiol."},{"key":"10.1016\/j.chembiol.2022.03.007_bib12","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1006\/jmbi.2001.4854","article-title":"Functional determinants of the Epstein-Barr virus protease","volume":"311","author":"Buisson","year":"2001","journal-title":"J.\u00a0Mol. Biol."},{"key":"10.1016\/j.chembiol.2022.03.007_bib13","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/S0022-2836(02)01040-9","article-title":"The crystal structure of the Epstein\u2013Barr virus protease shows rearrangement of the processed C terminus","volume":"324","author":"Buisson","year":"2002","journal-title":"J.\u00a0Mol. Biol."},{"key":"10.1016\/j.chembiol.2022.03.007_bib14","doi-asserted-by":"crossref","first-page":"2937","DOI":"10.1128\/jvi.68.5.2937-2946.1994","article-title":"Human cytomegalovirus maturational proteinase: expression in Escherichia coli, purification, and enzymatic characterization by using peptide substrate mimics of natural cleavage sites","volume":"68","author":"Burck","year":"1994","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.chembiol.2022.03.007_bib15","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1021\/co200038g","article-title":"Simple one-pot synthesis of disulfide fragments for use in disulfide-exchange screening","volume":"13","author":"Burlingame","year":"2011","journal-title":"ACS Comb. Sci."},{"key":"10.1016\/j.chembiol.2022.03.007_bib16","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1038\/s41586-019-1694-1","article-title":"The clinical KRAS(G12C) inhibitor AMG 510 drives anti-tumour immunity","volume":"575","author":"Canon","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.chembiol.2022.03.007_bib17","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1016\/S0092-8674(00)80157-9","article-title":"Structure of the human cytomegalovirus protease catalytic domain reveals a novel serine protease fold and catalytic triad","volume":"86","author":"Chen","year":"1996","journal-title":"Cell"},{"key":"10.1016\/j.chembiol.2022.03.007_bib18","doi-asserted-by":"crossref","first-page":"4524","DOI":"10.1128\/jvi.69.7.4524-4528.1995","article-title":"Human cytomegalovirus proteinase: candidate glutamic acid identified as third member of putative active-site triad","volume":"69","author":"Cox","year":"1995","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.chembiol.2022.03.007_bib19","series-title":"AMBER 16","author":"Case","year":"2016"},{"key":"10.1016\/j.chembiol.2022.03.007_bib20","doi-asserted-by":"crossref","first-page":"7445","DOI":"10.1074\/jbc.271.13.7445","article-title":"Active human cytomegalovirus protease is a dimer","volume":"271","author":"Darke","year":"1996","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.chembiol.2022.03.007_bib21","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.ejmech.2017.06.019","article-title":"Covalent inhibitors design and discovery","volume":"138","author":"De Cesco","year":"2017","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.chembiol.2022.03.007_bib22","doi-asserted-by":"crossref","first-page":"14831","DOI":"10.1073\/pnas.261560598","article-title":"RNase P-mediated inhibition of cytomegalovirus protease expression and viral DNA encapsidation by oligonucleotide external guide sequences","volume":"98","author":"Dunn","year":"2001","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.chembiol.2022.03.007_bib23","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.neuron.2018.06.030","article-title":"Alzheimer\u2019s disease-associated \u03b2-amyloid is rapidly seeded by herpesviridae to protect against brain infection","volume":"99","author":"Eimer","year":"2018","journal-title":"Neuron"},{"key":"10.1016\/j.chembiol.2022.03.007_bib24","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.2147\/IDR.S180908","article-title":"Letermovir for the prevention of cytomegalovirus infection and disease in transplant recipients: an evidence-based review","volume":"12","author":"El Helou","year":"2019","journal-title":"Infect. Drug Resist."},{"key":"10.1016\/j.chembiol.2022.03.007_bib25","series-title":"Proceedings of the Second International Conference on Knowledge Discovery and Data Mining","first-page":"226","article-title":"A density-based algorithm for discovering clusters in large spatial databases with noise","author":"Ester","year":"1996"},{"key":"10.1016\/j.chembiol.2022.03.007_bib26","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/s12985-017-0719-3","article-title":"Multiple sclerosis: an example of pathogenic viral interaction?","volume":"14","author":"Fierz","year":"2017","journal-title":"Virol. J."},{"key":"10.1016\/j.chembiol.2022.03.007_bib27","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.1110\/ps.9.9.1753","article-title":"Modeling of loops in protein structures","volume":"9","author":"Fiser","year":"2000","journal-title":"Protein Sci."},{"key":"10.1016\/j.chembiol.2022.03.007_bib28","doi-asserted-by":"crossref","first-page":"2500","DOI":"10.1093\/bioinformatics\/btg362","article-title":"ModLoop: automated modeling of loops in protein structures","volume":"19","author":"Fiser","year":"2003","journal-title":"Bioinformatics"},{"key":"10.1016\/j.chembiol.2022.03.007_bib29","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/S1367-5931(97)80009-9","article-title":"Recent advances in antiviral research: identification of inhibitors of the herpesvirus proteases","volume":"1","author":"Flynn","year":"1997","journal-title":"Curr. Opin. Chem. Biol."},{"key":"10.1016\/j.chembiol.2022.03.007_bib30","doi-asserted-by":"crossref","first-page":"1680","DOI":"10.1182\/blood-2016-07-723148","article-title":"In utero cytomegalovirus infection and development of childhood acute lymphoblastic leukemia","volume":"129","author":"Francis","year":"2017","journal-title":"Blood"},{"key":"10.1016\/j.chembiol.2022.03.007_bib31","author":"Frisch","year":"2016"},{"key":"10.1016\/j.chembiol.2022.03.007_bib32","doi-asserted-by":"crossref","first-page":"11382","DOI":"10.1021\/cr500255e","article-title":"Current and potential treatments for ubiquitous but neglected herpesvirus infections","volume":"114","author":"Gable","year":"2014","journal-title":"Chem. Rev."},{"key":"10.1016\/j.chembiol.2022.03.007_bib33","doi-asserted-by":"crossref","first-page":"3702","DOI":"10.1128\/jvi.68.6.3702-3712.1994","article-title":"The protease of herpes simplex virus type 1 is essential for functional capsid formation and viral growth","volume":"68","author":"Gao","year":"1994","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.chembiol.2022.03.007_bib34","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.apsb.2020.08.014","article-title":"Crystal structure of SARS-CoV-2 papain-like protease","volume":"11","author":"Gao","year":"2021","journal-title":"Acta Pharmaceutica Sinica. B"},{"key":"10.1016\/j.chembiol.2022.03.007_bib35","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1038\/nchembio.492","article-title":"Selective irreversible inhibition of a protease by targeting a noncatalytic cysteine","volume":"7","author":"Hagel","year":"2011","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.chembiol.2022.03.007_bib36","doi-asserted-by":"crossref","first-page":"4","DOI":"10.2174\/1568026616666160719163839","article-title":"Targeting non-catalytic cysteine residues through structure-guided drug discovery","volume":"17","author":"Hallenbeck","year":"2017","journal-title":"Curr. Top. Med. Chem."},{"key":"10.1016\/j.chembiol.2022.03.007_bib37","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1177\/2472555217732072","article-title":"A liquid chromatography\/mass spectrometry method for screening disulfide tethering fragments","volume":"23","author":"Hallenbeck","year":"2018","journal-title":"SLAS Discov."},{"key":"10.1016\/j.chembiol.2022.03.007_bib38","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1002\/cmdc.201200497","article-title":"Development and characterization of new peptidomimetic inhibitors of the West Nile virus NS2B-NS3 protease","volume":"8","author":"Hammamy","year":"2013","journal-title":"ChemMedChem"},{"key":"10.1016\/j.chembiol.2022.03.007_bib39","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/0166-3542(95)00976-0","article-title":"A rapid assay for determination of antiviral activity against human cytomegalovirus","volume":"32","author":"Hippenmeyer","year":"1996","journal-title":"Antiviral Res."},{"key":"10.1016\/j.chembiol.2022.03.007_bib40","doi-asserted-by":"crossref","first-page":"211","DOI":"10.4103\/1673-5374.226380","article-title":"Contributions of neurotropic human herpesviruses herpes simplex virus 1 and human herpesvirus 6 to neurodegenerative disease pathology","volume":"13","author":"Hogestyn","year":"2018","journal-title":"Neural Regen. Res."},{"key":"10.1016\/j.chembiol.2022.03.007_bib41","doi-asserted-by":"crossref","first-page":"14023","DOI":"10.1021\/bi9712697","article-title":"Active site cavity of herpesvirus proteases revealed by the crystal structure of herpes simplex virus protease\/inhibitor complex \u2021","volume":"36","author":"Hoog","year":"1997","journal-title":"Biochemistry"},{"key":"10.1016\/j.chembiol.2022.03.007_bib42","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1016\/j.cell.2018.01.006","article-title":"Targeting KRAS mutant cancers with a covalent G12C-specific inhibitor","volume":"172","author":"Janes","year":"2018","journal-title":"Cell"},{"key":"10.1016\/j.chembiol.2022.03.007_bib43","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1126\/science.1218231","article-title":"Linking crystallographic model and data quality","volume":"336","author":"Karplus","year":"2012","journal-title":"Science"},{"key":"10.1016\/j.chembiol.2022.03.007_bib44","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1021\/bi027045s","article-title":"Structural and biochemical studies of inhibitor binding to human cytomegalovirus protease","volume":"42","author":"Khayat","year":"2003","journal-title":"Biochemistry"},{"key":"10.1016\/j.chembiol.2022.03.007_bib45","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1016\/j.jmb.2011.06.032","article-title":"Enzyme inhibition by allosteric capture of an inactive conformation","volume":"411","author":"Lee","year":"2011","journal-title":"J.\u00a0Mol. Biol."},{"key":"10.1016\/j.chembiol.2022.03.007_bib46","doi-asserted-by":"crossref","first-page":"10087","DOI":"10.1021\/bi301305k","article-title":"Mapping inhibitor binding modes on an active cysteine protease via nuclear magnetic resonance spectroscopy","volume":"51","author":"Lee","year":"2012","journal-title":"Biochemistry"},{"key":"10.1016\/j.chembiol.2022.03.007_bib47","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1093\/bioinformatics\/btu830","article-title":"NMRFAM-SPARKY: enhanced software for biomolecular NMR spectroscopy","volume":"31","author":"Lee","year":"2015","journal-title":"Bioinformatics"},{"key":"10.1016\/j.chembiol.2022.03.007_bib48","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1107\/S2059798316018210","article-title":"Polder maps: improving OMIT maps by excluding bulk solvent","volume":"73","author":"Liebschner","year":"2017","journal-title":"Acta Crystallogr. Section D Struct. Biol."},{"key":"10.1016\/j.chembiol.2022.03.007_bib49","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1093\/infdis\/jiv352","article-title":"Characterization of cytomegalovirus breakthrough events in a phase 2 prophylaxis trial of letermovir (AIC246, MK 8228)","volume":"213","author":"Lischka","year":"2016","journal-title":"J.\u00a0Infect. Dis."},{"key":"10.1016\/j.chembiol.2022.03.007_bib50","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.chembiol.2012.12.006","article-title":"Developing irreversible inhibitors of the protein kinase cysteinome","volume":"20","author":"Liu","year":"2013","journal-title":"Chem. Biol."},{"key":"10.1016\/j.chembiol.2022.03.007_bib51","doi-asserted-by":"crossref","first-page":"3123","DOI":"10.1128\/JVI.78.6.3123-3132.2004","article-title":"Crystal structures of a multidrug-resistant human immunodeficiency virus type 1 protease reveal an expanded active-site cavity","volume":"78","author":"Logsdon","year":"2004","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.chembiol.2022.03.007_bib52","doi-asserted-by":"crossref","first-page":"3696","DOI":"10.1021\/acs.jctc.5b00255","article-title":"ff14SB: improving the accuracy of protein side chain and backbone parameters from ff99SB","volume":"11","author":"Maier","year":"2015","journal-title":"J.\u00a0Chem. Theor. Comput."},{"key":"10.1016\/j.chembiol.2022.03.007_bib53","first-page":"143","article-title":"Human cytomegalovirus and transplantation: drug development and regulatory issues","volume":"2","author":"McIntosh","year":"2016","journal-title":"J.\u00a0Virus Erad."},{"key":"10.1016\/j.chembiol.2022.03.007_bib54","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/B978-0-12-397918-6.00004-5","article-title":"Targeting protein kinases with selective and semipromiscuous covalent inhibitors","volume":"548","author":"Miller","year":"2014","journal-title":"Methods Enzymol."},{"key":"10.1016\/j.chembiol.2022.03.007_bib55","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1038\/nsmb1006","article-title":"Induced structure of a helical switch as a mechanism to regulate enzymatic activity","volume":"12","author":"Nomura","year":"2005","journal-title":"Nat. Struct. Mol. Biol."},{"key":"10.1016\/j.chembiol.2022.03.007_bib56","doi-asserted-by":"crossref","first-page":"23634","DOI":"10.1074\/jbc.270.40.23634","article-title":"Single-chain recombinant human cytomegalovirus protease. Activity against its natural protein substrate and fluorogenic peptide substrates","volume":"270","author":"Pinko","year":"1995","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.chembiol.2022.03.007_bib57","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/S0960-894X(99)00005-0","article-title":"Inhibition of human cytomegalovirus protease by enedione derivatives of thieno[2,3-d]oxazinones through a novel dual acylation\/alkylation mechanism","volume":"9","author":"Pinto","year":"1999","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.chembiol.2022.03.007_bib58","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1038\/383275a0","article-title":"Unique fold and active site in cytomegalovirus protease","volume":"383","author":"Qiu","year":"1996","journal-title":"Nature"},{"key":"10.1016\/j.chembiol.2022.03.007_bib59","doi-asserted-by":"crossref","first-page":"2874","DOI":"10.1073\/pnas.94.7.2874","article-title":"Crystal structure of varicella-zoster virus protease","volume":"94","author":"Qiu","year":"1997","journal-title":"Proc. Natl. Acad. Sci. U\u00a0S\u00a0A"},{"key":"10.1016\/j.chembiol.2022.03.007_bib60","doi-asserted-by":"crossref","first-page":"104707","DOI":"10.1016\/j.antiviral.2020.104707","article-title":"Identification and structural characterization of small molecule fragments targeting Zika virus NS2B-NS3 protease","volume":"175","author":"Quek","year":"2020","journal-title":"Antiviral Res."},{"key":"10.1016\/j.chembiol.2022.03.007_bib61","doi-asserted-by":"crossref","first-page":"e177","DOI":"10.1016\/S1473-3099(17)30143-3","article-title":"Congenital cytomegalovirus infection in pregnancy and the neonate: consensus recommendations for prevention, diagnosis, and therapy","volume":"17","author":"Rawlinson","year":"2017","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.chembiol.2022.03.007_bib62","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.4065\/mcp.2011.0309","article-title":"Antiviral drugs for viruses other than human immunodeficiency virus","volume":"86","author":"Razonable","year":"2011","journal-title":"Mayo Clinic Proc."},{"key":"10.1016\/j.chembiol.2022.03.007_bib63","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.neuron.2018.05.023","article-title":"Multiscale Analysis of independent Alzheimer\u2019s cohorts finds disruption of molecular, genetic, and clinical networks by human herpesvirus","volume":"99","author":"Readhead","year":"2018","journal-title":"Neuron"},{"key":"10.1016\/j.chembiol.2022.03.007_bib64","doi-asserted-by":"crossref","first-page":"12796","DOI":"10.1021\/bi001019h","article-title":"Functional consequences of the Kaposi\u2019s sarcoma-associated herpesvirus protease structure: regulation of activity and dimerization by conserved structural elements","volume":"39","author":"Reiling","year":"2000","journal-title":"Biochemistry"},{"key":"10.1016\/j.chembiol.2022.03.007_bib65","doi-asserted-by":"crossref","first-page":"3084","DOI":"10.1021\/ct400341p","article-title":"PTRAJ and CPPTRAJ: software for processing and analysis of molecular dynamics trajectory data","volume":"9","author":"Roe","year":"2013","journal-title":"J.\u00a0Chem. Theor. Comput."},{"key":"10.1016\/j.chembiol.2022.03.007_bib66","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1007\/s00280-017-3489-0","article-title":"Positioning of proteasome inhibitors in therapy of solid malignancies","volume":"81","author":"Roeten","year":"2018","journal-title":"Cancer Chemother. Pharmacol."},{"key":"10.1016\/j.chembiol.2022.03.007_bib67","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1038\/s41586-019-1669-2","article-title":"HP1 reshapes nucleosome core to promote phase separation of heterochromatin","volume":"575","author":"Sanulli","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.chembiol.2022.03.007_bib68","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1038\/nmeth.2089","article-title":"NIH Image to ImageJ: 25 years of image analysis","volume":"9","author":"Schneider","year":"2012","journal-title":"Nat. Methods"},{"key":"10.1016\/j.chembiol.2022.03.007_bib69","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1038\/nchembio.925","article-title":"Reversible targeting of noncatalytic cysteines with chemically tuned electrophiles","volume":"8","author":"Serafimova","year":"2012","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.chembiol.2022.03.007_bib70","doi-asserted-by":"crossref","first-page":"C3","DOI":"10.1152\/ajpcell.00281.2013","article-title":"Do you know the sex of your cells?","volume":"306","author":"Shah","year":"2014","journal-title":"Am. J. Physiology-Cell Physiol."},{"key":"10.1016\/j.chembiol.2022.03.007_bib71","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1038\/383279a0","article-title":"Three-dimensional structure of human cytomegalovirus protease","volume":"383","author":"Shieh","year":"1996","journal-title":"Nature"},{"key":"10.1016\/j.chembiol.2022.03.007_bib72","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1038\/nrd3410","article-title":"The resurgence of covalent drugs","volume":"10","author":"Singh","year":"2011","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.chembiol.2022.03.007_bib73","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.coviro.2011.07.009","article-title":"Viruses - from pathogens to vaccine carriers","volume":"1","author":"Small","year":"2011","journal-title":"Curr. Opin. Virol."},{"key":"10.1016\/j.chembiol.2022.03.007_bib74","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1111\/j.1432-1033.1994.tb20060.x","article-title":"In\u00a0vitro proteolytic activity and active-site identification of the human cytomegalovirus protease","volume":"226","author":"Stevens","year":"1994","journal-title":"Eur. J. Biochem."},{"key":"10.1016\/j.chembiol.2022.03.007_bib75","series-title":"Clinical Microbiology\/virology Reviews 209347Orig1s000. US Food and Drug Administration","first-page":"8","author":"Komatsu","year":"2016"},{"key":"10.1016\/j.chembiol.2022.03.007_bib76","series-title":"Clinical Microbiology\/virology Reviews 209939Orig1s000, 209940Orig1s000. US Food and Drug Administration","first-page":"29","author":"Komatsu","year":"2017"},{"key":"10.1016\/j.chembiol.2022.03.007_bib77","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1038\/383272a0","article-title":"A new serine-protease fold revealed by the crystal structure of human cytomegalovirus protease","volume":"383","author":"Tong","year":"1996","journal-title":"Nature"},{"key":"10.1016\/j.chembiol.2022.03.007_bib78","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1038\/1860","article-title":"Conserved mode of peptidomimetic inhibition and substrate recognition of human cytomegalovirus protease","volume":"5","author":"Tong","year":"1998","journal-title":"Nat. Struct. Biol."},{"key":"10.1016\/j.chembiol.2022.03.007_bib79","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1021\/co500132q","article-title":"Simple plate-based, parallel synthesis of disulfide fragments using the CuAAC click reaction","volume":"16","author":"Turner","year":"2014","journal-title":"ACS Comb. Sci."},{"key":"10.1016\/j.chembiol.2022.03.007_bib80","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1039\/D1MD00089F","article-title":"Irreversible inhibition of BoNT\/A protease: proximity-driven reactivity contingent upon a bifunctional approach","volume":"12","author":"Turner","year":"2021","journal-title":"RSC Med. Chem."},{"key":"10.1016\/j.chembiol.2022.03.007_bib81","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1007\/s13311-018-0611-x","article-title":"Anti-herpetic medications and reduced risk of dementia in patients with herpes simplex virus infections\u2014a nationwide, population-based cohort study in Taiwan","volume":"15","author":"Tzeng","year":"2018","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.chembiol.2022.03.007_bib82","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1002\/jcc.20035","article-title":"Development and testing of a general amber force field","volume":"25","author":"Wang","year":"2004","journal-title":"J.\u00a0Comput. Chem."},{"key":"10.1016\/j.chembiol.2022.03.007_bib83","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.jmgm.2005.12.005","article-title":"Automatic atom type and bond type perception in molecular mechanical calculations","volume":"25","author":"Wang","year":"2006","journal-title":"J.\u00a0Mol. Graphics Model."},{"key":"10.1016\/j.chembiol.2022.03.007_bib84","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1177\/095632020001100101","article-title":"The herpesvirus proteases as targets for antiviral chemotherapy","volume":"11","author":"Waxman","year":"2000","journal-title":"Antivir. Chem. Chemother."},{"key":"10.1016\/j.chembiol.2022.03.007_bib85","doi-asserted-by":"crossref","first-page":"7360","DOI":"10.1128\/jvi.67.12.7360-7372.1993","article-title":"Herpesvirus proteinase: site-directed mutagenesis used to study maturational, release, and inactivation cleavage sites of precursor and to identify a possible catalytic site serine and histidine","volume":"67","author":"Welch","year":"1993","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.chembiol.2022.03.007_bib86","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1107\/S0907444913015308","article-title":"Decision making in xia 2","volume":"69","author":"Winter","year":"2013","journal-title":"Acta Crystallogr. Section D Biol. Crystallogr."},{"key":"10.1016\/j.chembiol.2022.03.007_bib87","doi-asserted-by":"crossref","first-page":"e1005045","DOI":"10.1371\/journal.ppat.1005045","article-title":"D imerization-induced allosteric changes of the oxyanion-hole loop activate the pseudorabies virus assemblin pUL26N, a herpesvirus serine protease","volume":"11","author":"Z\u00fchlsdorf","year":"2015","journal-title":"PLoS Pathog."}],"container-title":["Cell Chemical Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2451945622001246?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2451945622001246?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T14:42:45Z","timestamp":1762526565000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2451945622001246"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5]]},"references-count":87,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2022,5]]}},"alternative-id":["S2451945622001246"],"URL":"https:\/\/doi.org\/10.1016\/j.chembiol.2022.03.007","relation":{},"ISSN":["2451-9456"],"issn-type":[{"value":"2451-9456","type":"print"}],"subject":[],"published":{"date-parts":[[2022,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Inhibiting a dynamic viral protease by targeting a non-catalytic cysteine","name":"articletitle","label":"Article Title"},{"value":"Cell Chemical Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.chembiol.2022.03.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}